EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking

Oumnia Masrour, Justine Morvan, Alison Rapin, Alexis Aimé, Agnès Burel, Valentine Genêt, Stéphanie Brisset, Dominique Lagadic-Gossmann, Edouard Bardou-Jacquet, Corinne Martin-Chouly

Digestive and Liver Disease · 2026-03 · 58 (3) · 355-364

DOI: 10.1016/j.dld.2025.12.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026-03. Verfasst von Oumnia Masrour und 9 weiteren Autor:innen. Beteiligte Einrichtung: CHU Rennes, Rennes F-35000, France. Hauptthemen laut MEDLINE: Smoking, Extracellular Vesicles, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: INSERM, Société Nationale Française de Gastro-Entérologie, Université de Rennes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) encompasses a spectrum of liver conditions, primarily driven by metabolic factors and characterized by steatosis. Extracellular vesicles and particles (EVPs) are emerging as biomarkers for liver diseases as they reflect the state of their cells of origin and carry molecular cargo that can influence disease progression. We aimed to explore the role of EVPs with MASLD progression, smoking impact and EVPs effect on macrophages. METHODS: We analyzed EVPs using nanoparticle tracking analysis, transmission electron microscopy and flow cytometry. Cytokine expressions were quantified in EVPs-exposed macrophages. RESULTS: We showed that EVP number is higher in patients with steatohepatitis and they were correlated with the severity of liver inflammation and steatosis, as well as with biological markers. In particular CD63+-ASGR1+-EVPs were notably more prevalent in blood of patients with steatohepatitis. Active smoking further increased EVP numbers and CD63+-ASGR1+-EVPs in MASLD patients. Functionally, exposure of macrophages to CD63+-EVPs from MASLD patients induced TGF-β and TIMP-1 secretion. CONCLUSION: This study highlights the potential of EVs as biomarkers for MASLD progression and their role in mediating disease mechanisms via intercellular communication, notably by their potential to contribute to fibrogenic signaling. Although exploratory, the study also highlights the potential impact of the exposome, particularly smoking, on MASLD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmokingExtracellular VesiclesLiver CirrhosisFatty LiverHepatocytesNon-alcoholic Fatty Liver DiseaseHumansBiomarkersDisease ProgressionFemaleMacrophagesMaleMiddle AgedAdultTetraspanin 30Tissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta

Stichwörter der Autor:innen

FibrosisMASLDMacrophageSteatosis

Substanzen

BiomarkersTetraspanin 30Tissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta

Autor:innen und Institutionen

  • CHU Rennes, Rennes F-35000, France.
  • CHU Rennes, Rennes F-35000, France; Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Biosit - UMS 3480, US_S 018, Rennes F-35000, France.
  • Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Biosit - UMS 3480, US_S 018, Rennes F-35000, France.
  • Biosit-Biogenouest, Université Rennes, Rennes 35000, France.
  • Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Biosit - UMS 3480, US_S 018, Rennes F-35000, France. Electronic address: corinne.chouly@univ-rennes.fr.

Förderung

  • INSERM
  • Société Nationale Française de Gastro-Entérologie
  • Université de Rennes

Zitieren

APA

Masrour, O., Morvan, J., Rapin, A., Aimé, A., Burel, A., Genêt, V., Brisset, S., Lagadic-Gossmann, D., Bardou-Jacquet, E., & Martin-Chouly, C. (2026). Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking. Digestive and Liver Disease, 58(3), 355-364. https://doi.org/10.1016/j.dld.2025.12.003

Vancouver

Masrour O, Morvan J, Rapin A, Aimé A, Burel A, Genêt V, et al. Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking. Digestive and Liver Disease. 2026;58(3):355-364. doi:10.1016/j.dld.2025.12.003

BibTeX
@article{Masrour2026,
  author = {Masrour, Oumnia and Morvan, Justine and Rapin, Alison and Aimé, Alexis and Burel, Agnès and Genêt, Valentine and Brisset, Stéphanie and Lagadic-Gossmann, Dominique and Bardou-Jacquet, Edouard and Martin-Chouly, Corinne},
  title = {Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking},
  journal = {Digestive and Liver Disease},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {355--364},
  doi = {10.1016/j.dld.2025.12.003}
}
Kostenlos starten →